Potency of an HIV-SAM™ vaccine in a heterologous prime-boost vaccination regimen

被引:0
|
作者
K Banerjee
Y Cu
Y Sun
K Hartog
A Dey
L Brito
A Verma
A Nandi
P Sarkar
NM Valiante
AJ Geall
SW Barnett
GR Otten
机构
[1] Novartis Vaccines and Diagnostics,
来源
关键词
Vaccine Delivery System; Boost Regimen; Vaginal Wash; Cell Culture Production; Replicon Particle;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Potency of an HIV-SAM™ vaccine in a heterologous prime-boost vaccination regimen
    Banerjee, K.
    Cu, Y.
    Sun, Y.
    Hartog, K.
    Dey, A.
    Brito, L.
    Verma, A.
    Nandi, A.
    Sarkar, P.
    Valiante, N. M.
    Geall, A. J.
    Barnett, S. W.
    Otten, G. R.
    [J]. RETROVIROLOGY, 2012, 9
  • [2] Heterologous prime-boost vaccination
    Lu, Shan
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2009, 21 (03) : 346 - 351
  • [3] Simplified steps to heterologous prime-boost HIV vaccine development?
    Michael, Nelson L.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2019, 129 (11): : 4572 - 4573
  • [4] Heterologous prime-boost vaccination with a peptidebased vaccine and viral vector improves antitumor therapy
    Alfei, F.
    Belnoue, E.
    Rossi, M.
    Derouazi, M.
    Devy-Dimanche, L.
    Santiago-Raber, M. L.
    [J]. SWISS MEDICAL WEEKLY, 2023, 153 : 10S - 10S
  • [5] Assessment of an LSDV-Vectored Vaccine for Heterologous Prime-Boost Immunizations against HIV
    Chapman, Ros
    van Diepen, Michiel
    Douglass, Nicola
    Galant, Shireen
    Jaffer, Mohamed
    Margolin, Emmanuel
    Ximba, Phindile
    Hermanus, Tandile
    Moore, Penny L.
    Williamson, Anna-Lise
    [J]. VACCINES, 2021, 9 (11)
  • [6] Jordanians' willingness to receive heterologous prime-boost COVID-19 vaccination and vaccine boosters
    Rababa'h, A. M.
    Abedalqader, N. N.
    Ababneh, M.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (23) : 7516 - 7525
  • [7] Heterologous Prime-Boost Immunizations with a Virosomal and an Alphavirus Replicon Vaccine
    Walczak, Mateusz
    de Mare, Arjan
    Riezebos-Brilman, Annelies
    Regts, Joke
    Hoogeboom, Baukje-Nynke
    Visser, Jeroen T.
    Fiedler, Marc
    Jansen-Duerr, Pidder
    van der Zee, Ate G. J.
    Nijman, Hans W.
    Wilschut, Jan
    Daemen, Toos
    [J]. MOLECULAR PHARMACEUTICS, 2011, 8 (01) : 65 - 77
  • [8] Heterologous Prime-Boost Vaccination with Commercial FMD Vaccines Elicits a Broader Immune Response than Homologous Prime-Boost Vaccination in Pigs
    Kim, Jaejo
    Lee, Seung-Heon
    Kim, Ha-Hyun
    Park, Jong-Hyeon
    Park, Choi-Kyu
    [J]. VACCINES, 2023, 11 (03)
  • [9] Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal
    Venkatraman, Navin
    Ndiaye, Birahim Pierre
    Bowyer, Georgina
    Wade, Djibril
    Sridhar, Saranya
    Wright, Daniel
    Powlson, Jonathan
    Ndiaye, Ibrahima
    Dieye, Siry
    Thompson, Craig
    Bakhoum, Momar
    Morter, Richard
    Capone, Stefania
    Del Sorbo, Mariarosaria
    Jamieson, Sophie
    Rampling, Tommy
    Datoo, Mehreen
    Roberts, Rachel
    Poulton, Ian
    Griffiths, Oliver
    Ballou, W. Ripley
    Roman, Francois
    Lewis, David J. M.
    Lawrie, Alison
    Imoukhuede, Egeruan
    Gilbert, Sarah C.
    Dieye, Tandakha N.
    Ewer, Katie J.
    Mboup, Souleymane
    Hill, Adrian V. S.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2019, 219 (08): : 1187 - 1197
  • [10] Pilot study of a potential novel heterologous prime-boost cancer vaccine
    Lynch, Candice M.
    Lemke, Caitlin D.
    Joshi, Vijaya
    Lubaroff, David
    Salem, Aliasager
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243